Eileen O’Meara

Also affiliated with Université de Montréal

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 13 papers. Top paper: “Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes”.

Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

JAMA(2020)10.1001/jama.2020.1906

N/A

6.7DataRank · unranked

539 citations

Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek +34 more

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

Nature Medicine(2022)10.1038/s41591-022-02102-9

N/A

1.7DataRank · unranked

67 citations

James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan +19 more

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER

Circulation(2022)10.1161/circulationaha.122.062832

N/A

1.5DataRank · unranked

56 citations

Muthiah Vaduganathan, Brian Claggett, Sheila M. Hegde, Maria Pabón, Ian J. Kulac +22 more

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

New England Journal of Medicine(2019)10.1056/nejmoa1911303

N/A

1.3DataRank · unranked

5622 citations

Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod, Felipe A. Martinez +43 more

Efficacy of Dapagliflozin in Black Versus White Patients With Heart Failure and Reduced Ejection Fraction

JACC Heart Failure(2021)10.1016/j.jchf.2021.08.006

N/A

0.900DataRank · unranked

49 citations

Modele O. Ogunniyi, Inder S. Anand, Akshay S. Desai, Mirta Díez, Jonathan G. Howlett +17 more

Dapagliflozin in Patients Hospitalized for Heart Failure: Primary Results of the DAPA ACT HF-TIMI 68 Randomized Clinical Trial and Meta-Analysis of Sodium-Glucose Cotransporter-2 Inhibitors in Patients Hospitalized for Heart Failure

Circulation(2025)10.1161/circulationaha.125.076575

N/A

0.794DataRank · unranked

37 citations

Siddharth M. Patel, Paul M. Haller, Abby L. Cange, Michael G. Palazzolo, Andrea Bellavia +23 more

Efficacy and Safety of Sodium–Glucose Co-Transporter 2 Inhibition According to Left Ventricular Ejection Fraction in DAPA-HF

European Journal of Heart Failure(2020)10.1002/ejhf.1867

N/A

0.557DataRank · unranked

40 citations

Scott D. Solomon, Pardeep S. Jhund, Silvio E. Inzucchi, Lars Køber, Mikhail N. Kosiborod +18 more

Clinical Implications of Subclinical Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction: The PARAGON-HF Study

European Journal of Heart Failure(2024)10.1002/ejhf.3167

N/A

0.434DataRank · unranked

17 citations

Riccardo M. Inciardi, Brian Claggett, Maja Čikeš, Li Liu, Narayana Prasad +10 more

Relationship Between Cardiac Structure and Function With Renal Function Trajectory and Outcomes in Patients With Heart Failure: Insights From the PARAGON-HF Trial

Circulation Heart Failure(2024)10.1161/circheartfailure.124.011942

N/A

0.358DataRank · unranked

5 citations

Safia Chatur, Sahmin Lee, Riccardo M. Inciardi, Martin Hongieh Abanda, Finnian R. Mc Causland +15 more

Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure

JACC Heart Failure(2025)10.1016/j.jchf.2025.102706

N/A

0.208DataRank · unranked

3 citations

Jan Bělohlávek, Andrej Dukát, Justin A. Ezekowitz, Sorel Goland, Béla Merkely +14 more

Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial

Journal of Cardiac Failure(2025)10.1016/j.cardfail.2025.01.009

N/A

0.208DataRank · unranked

3 citations

Hillary Mulder, Robert J. Mentz, Javed Butler, Carmine G. De Pasquale, Gregory D. Lewis +10 more

Prognostic Impact of Cardiovascular Versus Noncardiovascular Hospitalizations in Heart Failure With Preserved Ejection Fraction: Insights From TOPCAT

Journal of Cardiac Failure(2022)10.1016/j.cardfail.2022.05.004

N/A

0DataRank · unranked

7 citations

Brian Claggett, Eldrin F. Lewis, Eileen O’Meara, Nadine Clausell, Rafael Díaz +7 more

Drug Layering in Heart Failure

JACC Heart Failure(2021)10.1016/j.jchf.2021.06.011

N/A

0DataRank · unranked

47 citations

Larry A. Allen, Amr Abdin, JoAnn Lindenfeld, Eileen O’Meara, Carolyn S.P. Lam +7 more